Assessment of UGT Polymorphisms and Neonatal Jaundice

Seminars in Perinatology

Volumn 35, Issue 3, 2011, Pages 127-133

  Bartlett, Mark G ^a   Gourley, Glenn R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Bilirubin; Crigler Najjar syndrome; Gilbert's syndrome; Neonatal jaundice; UGT polymorphisms

Indexed keywords

AGAR; CALCIUM PHOSPHATE; COLESTYRAMINE; GLUCURONOSYLTRANSFERASE; NICOTINIC ACID; PHENOBARBITAL; RIFAMPICIN;

CLINICAL FEATURE; CRIGLER NAJJAR SYNDROME; CRIGLER NAJJAR SYNDROME I; CRIGLER NAJJAR SYNDROME II; DNA POLYMORPHISM; DRUG BINDING; DRUG COST; DRUG MECHANISM; GENE MUTATION; GILBERT DISEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; NEWBORN; NEWBORN ASSESSMENT; NEWBORN JAUNDICE; PHOTOTHERAPY; PLASMAPHERESIS; PRIORITY JOURNAL; REGULATOR GENE; REVIEW; URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE GENE;

CRIGLER-NAJJAR SYNDROME; GILBERT DISEASE; GLUCURONOSYLTRANSFERASE; HUMANS; HYPERBILIRUBINEMIA; INFANT, NEWBORN; POLYMORPHISM, GENETIC;

EID: 79957952794     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2011.02.006     Document Type: Review

References (134)

1. Gilbert A., Lereboullet P. La cholemie simple familiale. Sem Med 1901, 21:241-243.
2. Odell G.B., Gourley G.R. Hereditary hyperbilirubinemia. The Textbook of Gastroenterology and Nutrition in Infancy 1989, 949-967. Raven, New York. E. Lebenthal (Ed.).
3. Watson K.J., Gollan J.L. Gilbert's syndrome. Baillieres Clin Gastroenterol 1989, 3:337-355.
4. Berk P.D., Noyer C. The familial unconjugated hyperbilirubinemias. Semin Liver Dis 1994, 14:356-385.
5. Bergeron M.J., Gourley G.R. Disorders of bilirubin metabolism. Nathan and Oski's Hematology of Infancy and Childhood 2009, 103-145. Saunders Elsevier, Philadelphia. S.H. Orkin, D.E. Fisher, T. Look (Eds.).
6. Ashraf W., van Someren N., Quigley E.M., et al. Gilbert's syndrome and Ramadan: Exacerbation of unconjugated hyperbilirubinemia by religious fasting. J Clin Gastroenterol 1994, 19:122-124.
7. Alwall N., Laurell C.B., Nilsby I. Studies on hereditary in cases of "nonhemolytic bilirubinemia without direct van den Bergh reaction" (hereditary, nonhemolytic bilirubinemia). Acta Med Scand 1946, 124:114-125.
8. Foulk W.T., Butt H.R., Owen C.A., et al. Constitutional hepatic dysfunction (Gilbert's disease): Its natural history and related syndromes. Medicine 1959, 38:25-46.
9. Powell L.W., Hemingway E., Billing B.H., et al. Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). A study of 42 families. N Engl J Med 1967, 277:1108-1112.
10. Aono S., Adachi Y., Uyama E., et al. Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. Lancet 1995, 345:958-959.
11. Bosma P., Chowdhury J.R., Jansen P.H. Genetic inheritance of Gilbert's syndrome. Lancet 1995, 346:314-315.
12. Odell G.B. The Estrogenation of the Newborn: Neonatal Hyperbilirubinemia 1980, 39-41. Grune & Stratton, New York.
13. Bancroft J.D., Kreamer B., Gourley G.R. Gilbert syndrome accelerates development of neonatal jaundice. J Pediatr 1998, 132:656-660.
14. Monaghan G., McLellan A., McGeehan A., et al. Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn. J Pediatr 1999, 134:441-446.
15. Akaba K., Kimura T., Sasaki A., et al. Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese. J Hum Genet 1999, 44:22-25.
16. Laforgia N., Faienza M.F., Rinaldi A., et al. Neonatal hyperbilirubinemia and Gilbert's syndrome. J Perinat Med 2002, 30:166-169.
17. Trioche P., Chalas J., Francoual J., et al. Jaundice with hypertrophic pyloric stenosis as an early manifestation of Gilbert syndrome. Arch Dis Child 1999, 81:301-303.
18. Hua L., Shi D., Bishop P.R., et al. The role of UGT1A1*28 mutation in jaundiced infants with hypertrophic pyloric stenosis. Pediatr Res 2005, 58:881-884.
19. Sampietro M., Lupica L., Perrero L., et al. The expression of uridine diphosphate glucuronosyltransferase gene is a major determinant of bilirubin level in heterozygous beta-thalassaemia and in glucose-6-phosphate dehydrogenase deficiency. Br J Haematol 1997, 99:437-439.
20. Kaplan M., Renbaum P., Levy-Lahad E., et al. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: A dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci U S A 1997, 94:12128-12132.
21. Galanello R., Cipollina M.D., Dessi C., et al. Co-inherited Gilbert's syndrome: A factor determining hyperbilirubinemia in homozygous beta-thalassemia. Haematologica 1999, 84:103-105.
22. Galanello R., Perseu L., Melis M.A., et al. Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome. Br J Haematol 1997, 99:433-436.
23. Tzetis M., Kanavakis E., Tsezou A., et al. Gilbert syndrome associated with beta-thalassemia. Pediatr Hematol Oncol 2001, 18:477-484.
24. Sharma S., Vukelja S.J., Kadakia S. Gilbert's syndrome co-existing with and masking hereditary spherocytosis. Ann Hematol 1997, 74:287-289.
25. Watchko J.F., Lin Z., Clark R.H., et al. Complex multifactorial nature of significant hyperbilirubinemia in neonates. Pediatrics 2009, 124:e868-e877.
26. Kaplan M., Slusher T., Renbaum P., et al. (TA)n UDP-glucuronosyltransferase 1A1 promoter polymorphism in Nigerian neonates. Pediatr Res 2008, 63:109-111.
27. Black M., Billing B.H. Hepatic bilirubin udp-glucuronyl transferase activity in liver disease and Gilbert's syndrome. N Engl J Med 1969, 280:1266-1271.
28. Felsher B.F., Craig J.R., Carpio N. Hepatic bilirubin glucuronidation in Gilbert's syndrome. J Lab Clin Med 1973, 81:829-837.
29. Auclair C., Hakim J., Boivin H., et al. Bilirubin and paranitrophenol glucuronyl transferase activities of the liver in patients with Gilbert's syndrome. Enzyme 1976, 21:97-107.
30. Adachi Y., Yamashita M., Nanno T., et al. Proportion of conjugated bilirubin in bile in relation to hepatic bilirubin UDP-glucuronyltransferase activity. Clin Biochem 1990, 23:131-134.
31. Billing B.H., Williams R., Richards T.G. Defects in hepatic transport of bilirubin in congenital hyperbilirubinemia: An analysis of plasma bilirubin disappearance curves. Clin Sci 1964, 27:245-257.
32. Berk P.D., Bloomer J.R., Hower R.B., et al. Constitutional hepatic dysfunction (Gilbert's syndrome): A new definition based on kinetic studies with unconjugated radiobilirubin. Am J Med 1970, 49:296-305.
33. Okoliesanyi L., Ghidini O., Orlando R., et al. An evaluation of bilirubin kinetics with respect to the diagnosis of Gilbert's snydrome. Clin Sci Mol Med 1978, 54:539-547.
34. Goresky C.A., Gordon E.R., Shaffer E.A., et al. Definition of a conjugation dysfunction in Gilbert's syndrome: Studies of the handling of bilirubin loads and of the pattern of bilirubin conjugates secreted in bile. Clin Sci 1978, 55:63-71.
35. Debinski H.S., Lee C.S., Dhillon A.P., et al. UDP-glucuronosyltransferase in Gilbert's syndrome. Pathology 1996, 28:238-241.
36. Ritter J.K., Chen F., Sheen Y., et al. A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem 1992, 267:3257-3261.
37. Jansen P.L., Bosma P.J., Chowdhury J.R. Molecular biology of bilirubin metabolism. Prog Liver Dis 1995, 13:125-150.
38. Bosma P.J., Chowdhury J.R., Bakker C., et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995, 333:1171-1175.
39. Sampietro M., Lupica L., Perrero L., et al. TATA-box mutant in the promoter of the uridine diphosphate glucuronosyltransferase gene in Italian patients with Gilbert's syndrome. Ital J Gastroenterol Hepatol 1998, 30:194-198.
40. Monaghan G., Ryan M., Seddon R., et al. Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 1996, 347:578-581.
41. Ando Y., Chida M., Nakayama K., et al. The UGT1A1*28 allele is relatively rare in a Japanese population. Pharmacogenetics 1998, 8:357-360.
42. Koiwai O., Nishizawa M., Hasada K., et al. Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase. Hum Mol Genet 1995, 4:1183-1186.
43. Maruo Y., Sato H., Yamano T., et al. Gilbert syndrome caused by a homozygous missense mutation (Tyr486Asp) of bilirubin UDP-glucuronosyltransferase gene. J Pediatr 1998, 132:1045-1047.
44. Beutler E., Gelbart T., Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: A balanced polymorphism for regulation of bilirubin metabolism?. Proc Natl Acad Sci U S A 1998, 95:8170-8174.
45. Coelho H., Costa E., Vieira E., et al. A new case of (TA)8 allele in the UGT1A1 gene promoter in a Caucasian girl with Gilbert syndrome. Pediatr Hematol Oncol 2004, 21:371-374.
46. Fromke V.L., Miller D. Constitutional hepatic dysfunction (CHD; Gilbert's snydrome): A review with special reference to a characteristic increase and prolongation of the hyperbilirubinemic response to nicotinic acid. Medicine 1972, 51:451-464.
47. Rollinghoff W., Paumgartner G., Preisig R. Nicotinic acid test in the diagnosis of Gilbert's syndrome: Correlation with the bilirubin clearance. Gut 1981, 22:663-668.
48. Gentile S., Orzes N., Persico M., et al. Comparison of nicotinic acid and caloric restriction-induced hyperbilirubinemia in the diagnosis of Gilbert's syndrome. J Hepatol 1985, 1:537-545.
49. Gentile S., Rubba P., Persico M., et al. Improvement of the nicotinic acid test in the diagnosis of Gilbert's syndrome by pretreatment with indomethacin. Hepato Gastroenterol 1985, 33:267-269.
50. Gentile S., Marmo R., Persico M., et al. Dissociation between vascular and metabolic effects of nicotinic acid in Gilbert's syndrome. Clin Physiol 1990, 10:171-178.
51. Davidson A.R., Rojas-Bueno A., Thompson R.P.H., et al. Reduced caloric intake and nicotinic acid provocation test in the diagnosis of Gilbert's syndrome. BMJ 1975, 2:480.
52. Ohkubo H., Musha H., Okuda K. Studies on nicotinic acid interaction with bilirubin metabolism. Dig Dis Sci 1979, 24:700-704.
53. Gentile S., Tiribelli C., Persico M., et al. Dose dependence of nicotinic acid-induced hyperbilirubinemia and its dissociation from hemolysis in Gilbert's syndrome. J Lab Clin Med 1986, 107:166-171.
54. Dickey W., McAleer J.J., Callender M.E. The nicotinic acid provocation test and unconjugated hyperbilirubinaemia. Ulster Med J 1991, 60:49-52.
55. Murthy G.D., Byron D., Shoemaker D., et al. The utility of rifampin in diagnosing Gilbert's syndrome. Am J Gastroenterol 2001, 96:1150-1154.
56. Sieg A., Stiehl A., Raedsch R., et al. Gilbert's syndrome: Diagnosis by typical serum bilirubin pattern. Clin Chim Acta 1986, 154:41-47.
57. Sieg A., Konig R., Ullrich D., et al. Subfractionation of serum bilirubins by alkaline methanolysis and thin-layer chromatography. An aid in the differential diagnosis of icteric diseases. J Hepatol 1990, 11:159-164.
58. Ullrich D., Sieg A., Blume R., et al. Normal pathways for glucuronidation, sulphation and oxidation of paracetamol in Gilbert's syndrome. Eur J Clin Invest 1987, 17:237-240.
59. Adachi Y., Katoh H., Fuchi I., et al. Serum bilirubin fractions in healthy subjects and patients with unconjugated hyperbilirubinemia. Clin Biochem 1990, 23:247-251.
60. Berk P.B., Isola L.M. Specific defects in hepatic storage and clearance of bilirubin. Bile Pigments and Jaundice: Molecular, Metabolic and Medical Aspects 1986, 279-316. Marcel Dekker, New York. J.D. Ostrow (Ed.).
61. Evans D.A. Survey of the human acetylator polymorphism in spontaneous disorders. J Med Genet 1984, 21:243-253.
62. Siegmund W., Fengler J.D., Franke G., et al. N-acetylation and debrisoquine hydroxylation polymorphisms in patients with Gilbert's syndrome. Br J Clin Pharmacol 1991, 32:467-472.
63. Herman R.J., Chaudhary A., Szakacs C.B. Disposition of lorazepam in Gilbert's syndrome: Effects of fasting, feeding, and enterohepatic circulation. J Clin Pharmacol 1994, 34:978-984.
64. de Morais S.M., Uetrecht J.P., Wells P.G. Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome. Gastroenterology 1992, 102:577-586.
65. Esteban A., Perez-Mateo M. Gilbert's disease: A risk factor for paracetamol overdosage?. J Hepatol 1993, 18:257-258.
66. Prausa S.E., Fukuda T., Maseck D., et al. UGT genotype may contribute to adverse events following medication with mycophenolate mofetil in pediatric kidney transplant recipients. Clin Pharmacol Ther 2009, 85:495-500.
67. Wasserman E., Myara A., Lokiec F., et al. Severe CPT-11 toxicity in patients with Gilbert's syndrome: Two case reports. Ann Oncol 1997, 8:1049-1051.
68. Ewesuedo R.B., Iyer L., Das S., et al. Phase I clinical and pharmacogenetic study of weekly TAS-103 in patients with advanced cancer. J Clin Oncol 2001, 19:2084-2090.
69. Zucker S.D., Qin X., Rouster S.D., et al. Mechanism of indinavir-induced hyperbilirubinemia. Proc Natl Acad Sci U S A 2001, 98:12671-12676.
70. Bosma P.J. Inherited disorders of bilirubin metabolism. J Hepatol 2003, 38:107-117.
71. Black M., Sherlock S. Treatment of Gilbert's syndrome with phenobarbitone. Lancet 1970, 1:1359-1361.
72. Origa R, Galanello R, Perseu L, et al: Cholelithiasis in thalassemia major. Eur J Haematol 82:22-25,.
73. Stocker R., McDonagh A.F., Glazer A.N., et al. Antioxidant activities of bile pigments: Biliverdin and bilirubin. Methods Enzymol 1990, 186:301-309.
74. McDonagh A.F. Is bilirubin good for you?. Clin Perinatol 1990, 17:359-369.
75. Breimer L.H., Wannamethee G., Ebrahim S., et al. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem 1995, 41:1504-1508.
76. Schwertner H.A., Jackson W.G., Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 1994, 40:18-23.
77. Crigler J.F., Najjar V.A. Congenital familial nonhemolytic jaundice with kernicterus. Pediatrics 1952, 10:169-180.
78. Gourley G.R. Bilirubin metabolism and kernicterus. Adv Pediatr 1997, 44:173-229.
79. Shevell M.I., Majnemer A., Schiff D. Neurologic perspectives of Crigler-Najjar syndrome type I. J Child Neurol 1998, 13:265-269.
80. Childs B., Najjar V.A. Familial nonhemolytic jaundice with kernicterus; a report of two cases without neurologic damage. Pediatrics 1956, 18:369-377.
81. Blumenschein S.D., Kallen R.J., Storey B., et al. Familial nonhemolytic jaundice with late onset of neurological damage. Pediatrics 1968, 42:786-792.
82. Blaschke T.F., Berke P.D., Scharschmidt B.F., et al. Crigler-Najjar syndrome: An unusual course with development of neurological damage at age eighteen. Pediatr Res 1974, 8:573-590.
83. Labrune P.H., Myara A., Francoual J., et al. Cerebellar symptoms as the presenting manifestations of bilirubin encephalopathy in children with Crigler-Najjar type I disease. Pediatrics 1992, 89:768-770.
84. Chalasani N., Chowdhury N.R., Chowdhury J.R., et al. Kernicterus in an adult who is heterozygous for Crigler-Najjar syndrome and homozygous for Gilbert-type genetic defect. Gastroenterology 1997, 112:2099-2103.
85. Strauss K.A., Robinson D.L., Vreman H.J., et al. Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler-Najjar disease. Eur J Pediatr 2006, 165:306-319.
86. Arias I.M., Gartner L.M., Cohen M., et al. Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency. Clinical, biochemical, pharmacologic and genetic evidence for heterogeneity. Am J Med 1969, 47:395-409.
87. Gollan J.L., Huang S.M., Billing B., et al. Prolonged survival in three brothers with severe type 2 Crigler-Najjar syndrome. Ultrastructural and metabolic studies. Gastroenterology 1975, 68:1543-1555.
88. Gordon E.R., Shaffer E.A., Sass-Kortsak A. Bilirubin secretion and conjujation in the Crigler-Najjar syndrome type II. Gastroenterology 1976, 70:761-765.
89. Koiwai O., Aono S., Adachi Y., et al. Crigler-Najjar syndrome type II is inherited both as a dominant and as a recessive trait. Hum Mol Genet 1996, 5:645-647.
90. Clarke D.J., Moghrabi N., Monaghan G., et al. Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias. Clin Chim Acta 1997, 266:63-74.
91. Burchell B., Coughtrie M.W., Jansen P.L. Function and regulation of UDP-glucuronosyltransferase genes in health and liver disease: Report of the seventh International Workshop on glucuronidation, September 1993, Pitlochry, Scotland. Hepatol 1994, 20:1622-1630.
92. Seppen J., Bosma P.J., Goldhoorn B.G., et al. Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase. J Clin Invest 1994, 94:2385-2391.
93. Labrune P., Myara A., Hadchouel M., et al. Genetic heterogeneity of Crigler-Najjar syndrome type I: A study of 14 cases. Hum Genet 1994, 94:693-697.
94. Gantla S., Bakker C.T., Deocharan B., et al. Splice-site mutations: A novel genetic mechanism of Crigler-Najjar syndrome type 1. Am J Hum Genet 1998, 62:585-592.
95. Szabo L., Kovács Z., Ebrey P.B. Crigler-Najjar syndrome. Acta Paediatr Hung 1962, 3:49-70.
96. Fevery J., Blanckaert N., Heirwegh K.P.M., et al. Unconjugated bilirubin and an increased proportion of bilirubin monoconjugates in the bile of patients with Gilbert's syndrome and Crigler-Najjar disease. J Clin Invest 1977, 60:970-979.
97. Duhamel G., Blanckaert N., Metreau J.M., et al. An unusual case of Crigler-Najjar disease in the adult. Classification into types I and II revisited. J Hepatol 1985, 1:47-53.
98. Sinaasappel M., Jansen P.L. The differential diagnosis of Crigler-Najjar disease, types 1 and 2, by bile pigment analysis. Gastroenterology 1991, 100:783-789.
99. Childs B., Sidbury J.B., Migeon C.J. Glucuronic acid conjugation by patients with familial nonhemolytic jaundice and their relatives. Pediatrics 1959, 23:903-913.
100. Szabo L., Ebrey P. Studies on the inheritance of Crigler-Najjar syndrome by the menthol test. Acta Paediatr Hung 1963, 4:153-159.
101. Kadakol A., Ghosh S.S., Sappal B.S., et al. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert Syndromes: Correlation of genotype to phenotype. Hum Mutat 2000, 16:297-306.
102. Francoual J., Trioche P., Mokrani C., et al. Prenatal diagnosis of Crigler-Najjar syndrome type I by single-strand conformation polymorphism (SSCP). Prenat Diagn 2002, 22:914-916.
103. Ciotti M., Obaray R., Martin M.G., et al. Genetic defects at the UGT1 locus associated with Crigler-Najjar type I disease, including a prenatal diagnosis. Am J Med Genet 1997, 68:173-178.
104. Mair B., Klempner L.B. Abnormally high values for direct bilirubin in the serum of newborns as measured with the DuPont aca. Am J Clin Pathol 1987, 87:642-644.
105. Odell G.B., Schutta H.S. Bilirubin encephalopathy. Cerebral Energy Metabolism and Metabolic Encephalopathy 1985, 229-261. Plenum Publishing Corporation, New York. D.W. McCandless (Ed.).
106. Moghrabi N., Clarke D.J., Burchell B., et al. Cosegregation of intragenic markers with a novel mutation that causes Crigler-Najjar syndrome type I: Implication in carrier detection and prenatal diagnosis. Am J Hum Genet 1993, 53:722-729.
107. van der Veere C.N., Sinaasappel M., McDonagh A.F., et al. Current therapy for Crigler-Najjar syndrome type 1: Report of a world registry. Hepatol 1996, 24:311-315.
108. Rubaltelli F.F., Novello A., Zancan L., et al. Serum and bile bilirubin pigments in the differential diagnosis of Crigler-Najjar disease. Pediatrics 1994, 94:553-556.
109. Agati G., Fusi F., Pratesi S., et al. Bilirubin photoisomerization products in serum and urine from a Crigler-Najjar type I patient treated by phototherapy. J Photochem Photobiol B-Biol 1998, 47:181-189.
110. Job H., Hart G., Lealman G. Improvements in long term phototherapy for patients with Crigler-Najjar syndrome type I. Phys Med Biol 1996, 41:2549-2556.
111. Nydegger A., Bednarz A., Hardikar W. Use of daytime phototherapy for Crigler-Najjar disease. J Paediatr Child Health 2005, 41:387-389.
112. Odell G.B., Gutcher G.R., Whitington P.F., et al. Enteral administration of agar as an effective adjunct to phototherapy of neonatal hyperbilirubinemia. Pediatr Res 1983, 17:810-814.
113. Arrowsmith W.A., Payne R.B., Littlewood J.M. Comparison of treatments for congenital nonobstructive nonhaemolytic hyperbilirubinaemia. Arch Dis Child 1975, 50:197-201.
114. Suresh G., Lucey J.F. Lack of deafness in Crigler-Najjar syndrome type 1: A patient survey. Pediatrics 1997, 100:E9.
115. van der Veere C.N., Jansen P.L., Sinaasappel M., et al. Oral calcium phosphate: A new therapy for Crigler-Najjar disease?. Gastroenterology 1997, 112:455-462.
116. Kotal P., van der Veere C.N., Sinaasappel M., et al. Intestinal excretion of unconjugated bilirubin in man and rats with inherited unconjugated hyperbilirubinemia. Pediatr Res 1997, 42:195-200.
117. Kemper K., Horwitz R.I., McCarthy P. Decreased neonatal serum bilirubin with plain agar: A meta-analysis. Pediatrics 1988, 82:631-638.
118. Sherker A.H., Heathcote J. Acute hepatitis in Crigler-Najjar syndrome. Am J Gastroenterol 1987, 82:883-885.
119. Prager M.C., Johnson K.L., Ascher N.L., et al. Anesthetic care of patients with Crigler-Najjar syndrome. Anesth Analg 1992, 74:162-164.
120. Rubaltelli F.F. Current drug treatment options in neonatal hyperbilirubinaemia and the prevention of kernicterus. Drugs 1998, 56:23-30.
121. Drummond G.S., Kappas A. Chemoprevention of severe neonatal hyperbilirubinemia. Semin Perinatol 2004, 28:365-368.
122. Whitington P.F., Emond J.C., Heffron T., et al. Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1. Lancet 1993, 342:779-780.
123. Rela M., Muiesan P., Andreani P., et al. Auxiliary liver transplantation for metabolic diseases. Transplant Proc 1997, 29:444-445.
124. Rela M., Muiesan P., Vilca-Melendez H., et al. Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type I. Ann Surg 1999, 229:565-569.
125. Kaufman S.S., Wood R.P., Shaw B.W., et al. Orthotopic liver transplantation for type 1 Crigler-Najjar syndrome. Hepatol 1986, 6:1259-1262.
126. Shevell M.I., Bernard B., Adelson J.W., et al. Crigler-Najjar syndrome type I: Treatment by home phototherapy followed by orthotopic hepatic transplantation. J Pediatr 1987, 110:429-431.
127. Sokal E.M., Silva E.S., Hermans D., et al. Orthotopic liver transplantation for Crigler-Najjar type I disease in six children. Transplantation 1995, 60:1095-1098.
128. McDiarmid S.V., Millis M.J., Olthoff K.M., et al. Indications for pediatric liver transplantation. Pediatr Transplant 1998, 2:106-116.
129. Rela M., Muiesan P., Heaton N.D., et al. Orthotopic liver transplantation for hepatic-based metabolic disorders. Transpl Int 1995, 8:41-44.
130. Mowat A.P. Orthotopic liver transplantation in liver-based metabolic disorders. Eur J Pediatr 1992, 151(suppl 1):S32-S38.
131. Gridelli B., Lucianetti A., Gatti S., et al. Orthotopic liver transplantation for Crigler-Najjar type I syndrome. Transplant Proc 1997, 29:440-441.
132. Pratschke J., Steinmuller T., Bechstein W.O., et al. Orthotopic liver transplantation for hepatic associated metabolic disorders. Clin Transpl 1998, 12:228-232.
133. Toietta G., Mane V.P., Norona W.S., et al. Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector. Proc Natl Acad Sci U S A 2005, 102:3930-3935.
134. Schauer R., Stangl M., Lang T., et al. Treatment of Crigler-Najjar type 1 disease: Relevance of early liver transplantation. J Pediatr Surg 2003, 38:1227-1231.